Logo for ME Therapeutics Holdings Inc.
METX
0.00%

ME Therapeutics Holdings Inc.

Status
ActiveT2
Issued & Outstanding30,388,556
Reserved for Issuance7,109,716
CurrencyCAD
CSE IndexCSE Composite

Quote

Last Price—0.00 (0.00%)
Volume0
Change0.00
Bid Size
0
Bid Price—
Ask Price—
Ask Size
0
Prev Close—
Open—
Day High—
Day Low—
52 Week High
—
52 Week Low
—

ME Therapeutics Holdings Inc.

Charts by TradingView

Depth Display

Recent Trades

About

ME Therapeutics Holdings Inc.

Listing Date
October 12, 2023
ME Therapeutics is an early stage Vancouver based biotechnology company involved in the discovery and development of novel immuno oncology therapeutics targeting immune suppression in cancer. Our main focus is on overcoming the suppressive effects of an important class of immune cells called myeloid cells in order to enhance anti-tumour immunity.